Increased expression of Akt2 and activity of PI3K and cell proliferation with the ascending of tumor grade of human gliomas

Clinical Neurology and Neurosurgery

Volumn 112, Issue 4, 2010, Pages 324-327

  Wang, Guangxiu ^a   Kang, Chunsheng ^a   Pu, Peiyu ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Akt2; Cell proliferation; Gliomas; PI3K

Indexed keywords

KI 67 ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B BETA;

ARTICLE; BRAIN TISSUE; CANCER GRADING; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTINS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 77950050376     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2010.01.003     Document Type: Article

References (29)

1. Testa J.R., and Bellacosa A. AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA 98 20 (2001) 10983-10985
2. Pu P., Kang C., Li J., Jiang H., and Cheng J. The effects of antisense AKT2 RNA on the inhibition of malignant glioma cell growth in vitro and in vivo. J Neurooncol 76 1 (2006) 1-11
3. Foster K., Wang Y., Zhou D., and Wright C. Dependence on PI3K/Akt signaling for malignant rhabdoid tumor cell survival. Cancer Chemother Pharmacol 63 5 (2009) 783-791
4. Mende I., Malstrom S., Tsichlis P.N., Vogt P.K., and Aoki M. Oncogenic transformation induced by membrane-targeted Akt2 and Akt3. Oncogene 20 32 (2001) 4419-4423
5. Arboleda M.J., Lyons J.F., Kabbinavar F.F., Bray M.R., Snow B.E., Ayala R., et al. Overexpression of AKT2/protein kinase B beta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res 63 1 (2003) 196-220
6. Lee S., Choi E.J., Jin C., and Kim D.H. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line. Gynecol Oncol 97 1 (2005) 26-34
7. Toulany M., Dittmann K., Fehrenbacher B., Schaller M., Baumann M., and Rodemann H.P. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro. DNA Repair (Amst) 7 10 (2008) 1746-1756
8. Nicholson K.M., and Anderson N.G. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14 5 (2002) 381-395
9. Pu P., Kang C., Li J., and Jiang H. Antisense and dominant-negative AKT2 cDNA inhibits glioma cell invasion. Tumour Biol 25 4 (2004) 172-178
10. Yuan Z.Q., Sun M., Feldman I., Wang G., Ma X., Jiang C., et al. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Oncogene 19 19 (2000) 2324-2330
11. Kang C.S., Pu P.Y., Li J., and Wang G.X. Inhibitory effect of antisense and dominant-negative AKT2 constructs on proliferation of glioma cell line TJ905. Ai Zheng 23 11 (2004) 1267-1272
12. Lin X., Böhle A.S., Dohrmann P., Leuschner I., Schulz A., Kremer B., et al. Overexpression of phosphatidylinositol 3-kinase in human lung cancer. Langenbecks Arch Surg 386 4 (2001) 293-301
13. Cheng J.Q., Ruggeri B., Klein W.M., Sonoda G., Altomare D.A., Watson D.K., et al. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sci USA 93 8 (1996) 3636-3641
14. Liao Y., Grobholz R., Abel U., Trojan L., Michel M.S., Angel P., et al. Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer. Int J Cancer 107 4 (2003) 676-680
15. Mukohara T., Kudoh S., Yamauchi S., Kimura T., Yoshimura N., Kanazawa H., et al. Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC). Lung Cancer 41 2 (2003) 123-130
16. Nakayama H., Ikebe T., Beppu M., and Shirasuna K. High expression levels of nuclear factor kappaB. IkappaB kinase alpha and Akt kinase in squamous cell carcinoma of the oral cavity. Cancer 92 12 (2001) 3037-3044
17. Ringel M.D., Hayre N., Saito J., Saunier B., Schuppert F., Burch H., et al. Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res 61 16 (2001) 6105-6111
18. Wang S.L., Li F., Pu P.Y., Wang G.X., Peng Q., and Wang C.Y. The establishment and characterization of human glioblastoma cell lines TJ899 and TJ905. Tianjin Med J 24 (1996) 416-418
19. Scheid M.P., and Woodgett J.R. Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett 546 1 (2003) 108-112
20. Hill M.M., and Hemmings B.A. Inhibition of protein kinase B/Akt. implications for cancer therapy. Pharmacol Ther 93 2-3 (2002) 243-251
21. Mayo L.D., and Donner D.B. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci USA 98 20 (2001) 11598-11603
22. Moral M., and Paramio J.M. Akt pathway as a target for therapeutic intervention in HNSCC. Histol Histopathol 3 10 (2008) 1269-1278
23. Kim D., Kim S., Koh H., Yoon S.O., Chung A.S., Cho K.S., et al. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J 15 11 (2001) 1953-1962
24. Park B.K., Zeng X., and Glazer R.I. Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. Cancer Res 61 20 (2001) 7647-7653
25. Choe G., Horvath S., Cloughesy T.F., Crosby K., Seligson D., Palotie A., et al. Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res 63 11 (2003) 2742-2746
26. Schlegel J., Piontek G., and Mennel H.D. Activation of the anti-apoptotic Akt/protein kinase B pathway in human malignant gliomas in vivo. Anticancer Res 22 5 (2002) 2837-2840
27. Chakravarti A., Zhai G., Suzuki Y., Sarkesh S., Black P.M., Muzikansky A., et al. The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. J Clin Oncol 22 10 (2004) 1926-1933
28. Knobbe C.B., and Reifenberger G. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol 13 4 (2003) 507-518
29. Zhang B., Gu F., She C., Guo H., Li W., Niu R., et al. Reduction of Akt2 inhibits migration and invasion of glioma cells. Int J Cancer 125 3 (2009) 585-595